The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis
Open accessAbstract
Human mastocytosis is characterized by increased mast cells. It usually occurs as a sporadic disease that is often transient and limited in children and persistent or progressive in adults. The c-KIT protooncogene encodes KIT, a tyrosine kinase that is the receptor for mast cell growth factor. Because mutated KIT can transform cells, we examined c-KIT in skin lesions of 22 patients with sporadic mastocytosis and 3 patients with familial mastocytosis. All patients with adult sporadic mastocytosis had somatic c-KIT mutations in codon 816 causing substitution of valine for aspartate and spontaneous activation of mast cell growth factor receptor (P= 0.0001). A subset of four pediatric onset cases with clinically unusual disease also had codon 816 activating mutations substituting valine, tyrosine, or phenylalanine for aspartate. Typical pediatric patients lacked 816 mutations, but limited sequencing showed three of six had a novel dominant inactivating mutation substituting lysine for glutamic acid in position 839, the site of a potential salt bridge that is highly conserved in receptor tyrosine kinases. No c-KIT mutations were found in the entire coding region of three patients with familial mastocytosis. We conclude that c-KIT somatic mutations substituting valine in position 816 of KIT are characteristic of sporadic adult mastocytosis and may cause this disease. Similar mutations causing activation of the mast cell growth factor receptor are found in children apparently at risk for extensive or persistent disease. In contrast, typical pediatric mastocytosis patients lack these mutations and may express inactivating c-KIT mutations. Familial mastocytosis, however, may occur in the absence of c-KIT coding mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
Hanks, S. K., Quinn, A. M., & Hunter, T. (1988) · Science · doi:10.1126/science.3291115 · Cited by 5,039
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,490
SH2 and SH3 Domains: Elements that Control Interactions of Cytoplasmic Signaling Proteins
Koch, C. A., Anderson, D., Moran, M. F., Ellis, C., & Pawson, T. (1991) · Science · doi:10.1126/science.1708916 · Cited by 1,868
Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.
Yarden, Y., Kuang, W. J., Yang-Feng, T., Coussens, L., Munemitsu, S., Dull, T. J., Chen, E., Schlessinger, J., Francke, U., & Ullrich, A. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02655.x · Cited by 1,574
The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene
Geissler, E. N., Ryan, M. A., & Housman, D. E. (1988) · Cell · doi:10.1016/0092-8674(88)90020-7 · Cited by 1,287
Crystal structure of the tyrosine kinase domain of the human insulin receptor
Hubbard, S. R., Wei, L., & Hendrickson, W. A. (1994) · Nature · doi:10.1038/372746a0 · Cited by 1,080
The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus
Chabot, B., Stephenson, D. A., Chapman, V. M., Besmer, P., & Bernstein, A. (1988) · Nature · doi:10.1038/335088a0 · Cited by 994
Nagata, H., Worobec, A. S., Oh, C. K., Chowdhury, B. A., Tannenbaum, S., Suzuki, Y., & Metcalfe, D. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10560 · Cited by 872
Self-citationFuritsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., Sugahara, H., Butterfield, J. H., Ashman, L. K., & Kanayama, Y. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116761 · Cited by 816
Qiu, F. H., Ray, P., Brown, K., Barker, P. E., Jhanwar, S., Ruddle, F. H., & Besmer, P. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02907.x · Cited by 697
Longley, B. J., Tyrrell, L., Lu, S.-Z., Ma, Y.-S., Langley, K., Ding, T.-G., Duffy, T., Jacobs, P., Tang, L. H., & Modlin, I. (1996) · Nature Genetics · doi:10.1038/ng0396-312 · Cited by 607
Self-citationFamilial gastrointestinal stromal tumours with germline mutation of the KIT gene
Nishida, T., Hirota, S., Taniguchi, M., Hashimoto, K., Isozaki, K., Nakamura, H., Kanakura, Y., Tanaka, T., Takabayashi, A., Matsuda, H., et al. (1998) · Nature Genetics · doi:10.1038/1209 · Cited by 586
Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.
Giebel, L. B., & Spritz, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8696 · Cited by 383
Classification and Diagnosis of Mastocytosis: Current Status
Metcalfe, D. D. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12468882 · Cited by 346
Self-citationThe c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis.
Iemura, A., Tsai, M. M., Ando, A., Wershil, B. K., & Galli, S. J. (1994) · PubMed · Cited by 278
Kitayama, H., Kanakura, Y., Furitsu, T., Tsujimura, T., Oritani, K., Ikeda, H., Sugahara, H., Mitsui, H., Kanayama, Y., & Kitamura, Y. (1995) · Blood · doi:10.1182/blood.v85.3.790.bloodjournal853790 · Cited by 233
The mast cell and mast cell disease
Longley, J., Duffy, T. P., & Kohn, S. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)90336-4 · Cited by 195
Huang, S., Luca, M., Gutman, M., McConkey, D. J., Langley, K. E., Lyman, S. D., & Bar‐Eli, M. (1996) · PubMed · Cited by 167
Tsujimura, T., Furitsu, T., Morimoto, M., Isozaki, K., Nomura, S., Matsuzawa, Y., Kitamura, Y., & Kanakura, Y. (1994) · Blood · doi:10.1182/blood.v83.9.2619.2619 · Cited by 163
Funasaka, Y., Boulton, T., Cobb, M., Yarden, Y., Fan, B., Lyman, S. D., Williams, D. E., Anderson, D. M., Zakut, R., & Mishima, Y. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.2.197 · Cited by 161
Loss of c-kit expression in cultured melanoma cells.
Lassam, N. J., & Bickford, S. (1992) · PubMed · Cited by 159
Spritz, R. A., Giebel, L. B., & Holmes, S. A. (1992) · PubMed · Cited by 159
Soter, N. A. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12468973 · Cited by 139
Mekori, Y. A., Oh, C. K., & Metcalfe, D. D. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.7.3775 · Cited by 125
Self-citationTsujimura, T., Furitsu, T., Morimoto, M., Kanayama, Y., Nomura, S., Matsuzawa, Y., Kitamura, Y., & Kanakura, Y. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000236870 · Cited by 123
Piao, X., & Bernstein, A. (1996) · Blood · doi:10.1182/blood.v87.8.3117.bloodjournal8783117 · Cited by 112
KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells.
Zakut, R., Perlis, R. H., Eliyahu, S., Yarden, Y., Givol, D., Lyman, S. D., & Halaban, R. (1993) · PubMed · Cited by 104
Tsujimura, T., Morimoto, M., Hashimoto, K., Moriyama, Y., Kitayama, H., Matsuzawa, Y., Kitamura, Y., & Kanakura, Y. (1996) · Blood · doi:10.1182/blood.v87.1.273.273 · Cited by 102
Role of Aspartic Acid 814 in the Function and Expression of c-kit Receptor Tyrosine Kinase
Moriyama, Y., Tsujimura, T., Hashimoto, K., Morimoto, M., Kitayama, H., Matsuzawa, Y., Kitamura, Y., & Kanakura, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3347 · Cited by 72
c-kit Mutation in a Population of Patients with Mastocytosis
Nagata, H., Okada, T., Worobec, A. S., Semere, T., & Metcalfe, D. D. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000237541 · Cited by 71
Self-citationHashimoto, K., Tsujimura, T., Moriyama, Y., Yamatodani, A., Kimura, M., Tohya, K., Morimoto, M., Kitayama, H., Kanakura, Y., & Kitamura, Y. (1996) · Europe PMC (PubMed Central) · Cited by 63
Klüppel, M., Nagle, D. L., Bućan, M., & Bernstein, A. (1997) · Development · doi:10.1242/dev.124.1.65 · Cited by 52
Larue, L., Dougherty, N., Porter, S. D., & Mintz, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7816 · Cited by 41
Cited by
The World Health Organization (WHO) classification of the myeloid neoplasms
Vardiman, J. W., Harris, N. L., & Brunning, R. D. (2002) · Blood · doi:10.1182/blood-2002-04-1199 · Cited by 2,197
Buchdunger, E., Cioffi, C. L., Law, N., Stover, D., Ohno-Jones, S., Druker, B. J., & Lydon, N. B. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38879-2 · Cited by 1,274
Biology of Gastrointestinal Stromal Tumors
Corless, C. L., Fletcher, J. A., & Heinrich, M. C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.140 · Cited by 1,224
Diagnostic criteria and classification of mastocytosis: a consensus proposal
Valent, P., Horny, H.-P., Escribano, L., Longley, B. J., Li, C. Y., Schwartz, L. B., Marone, G., Nuñez, R., Akin, C., Sotlar, K., et al. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00038-8 · Cited by 1,108
Self-citationHeinrich, M. C., Griffith, D. J., Druker, B. J., Wait, C. L., Ott, K. A., & Zigler, A. J. (2000) · Blood · doi:10.1182/blood.v96.3.925 · Cited by 1,071
Metadata
- Authors
- Longley, B. J., Metcalfe, D. D., Tharp, M., Wang, X., Tyrrell, L., Lu, S.-Z., Heitjan, D., & Ma, Y.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-02-16
- Volume
- 96
- Issue
- 4
- Pages
- 1609-1614
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2156160133
- Cited by
- 552
- References
- 33
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.